Clinical Evaluation of Plasma Fibronectin Level as a Biomarker of Preeclampsia

Objective: To evaluate the clinical feasibility of plasma fibronectin as a biomarker and predictor for preeclampsia.

[1]  J. Roberts,et al.  High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. , 1991, American journal of obstetrics and gynecology.

[2]  P. Finley,et al.  Plasma Levels of Fibronectin and Prostacyclin Metabolite in Peripartum Preeclamptic Women , 1990, American journal of perinatology.

[3]  J. Peters,et al.  Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. , 1990, American journal of obstetrics and gynecology.

[4]  A. Woolf,et al.  Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. , 1989, The Journal of laboratory and clinical medicine.

[5]  E. Mammen,et al.  Preeclampsia, delivery, and the hemostatic system. , 1987, American journal of obstetrics and gynecology.

[6]  R. Sokol,et al.  Mechanisms for reduced colloid osmotic pressure in preeclampsia. , 1987, American journal of obstetrics and gynecology.

[7]  B. A. Jensen,et al.  Plasma Fibronectin Concentration in Normal Pregnancy and Pre‐Eclampsia , 1987, Acta obstetricia et gynecologica Scandinavica.

[8]  J. Holmberg,et al.  Plasma and Amniotic Fluid Concentrations of Fibronectin During Normal Pregnancy , 1986, Obstetrics and gynecology.

[9]  C. Loadholt,et al.  Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. , 1986, American journal of obstetrics and gynecology.

[10]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.

[11]  V. Stecher,et al.  The effect of antiinflammatory drugs on plasma fibronectin. , 1985, Journal of Rheumatology.

[12]  M. Brown,et al.  Human fibronectin metabolism. , 1985, The Journal of clinical investigation.

[13]  S. Uzan,et al.  PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPY , 1985, The Lancet.

[14]  T. Stubbs,et al.  Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. , 1984, American journal of obstetrics and gynecology.

[15]  M. Karplus,et al.  The dynamics of proteins. , 1982, Scientific American.

[16]  F. Blumenstock,et al.  Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients. , 1981, Journal of Laboratory and Clinical Medicine.

[17]  M. Mosesson,et al.  The structure and biologic activities of plasma fibronectin. , 1980, Blood.